Type 1 Diabetes News

Study finds individuals with the greatest fear of physical activity had the poorest control of their diabetes.

A 55-year-old grandmother is producing insulin on her own after her islet cells were removed from her pancreas and implanted into her forearm a few weeks ago at The Methodist Hospital in Houston.

Researchers have transformed cells from human skin into cells that produce insulin, the hormone used to treat diabetes. The breakthrough may one day lead to new treatments or even a cure for the millions of people affected by the disease, researchers say.

Hypoglycemia is difficult to treat, particularly in children younger than five years of age, because of difficulties in administering the correct glucose dose as well as patient compliance. Researchers presented data that demonstrated how a new approach that could change the way this disorder is managed in millions of pediatric diabetes patients worldwide.

A review of studies reveals that the newer, long-acting insulin medications offer only a slight benefit over NPH in terms of blood glucose control in type 1 diabetes. Researchers did see a clear benefit of long-acting insulin in reducing the risk for hypoglycemia, particularly at night.

A study by researchers at the Joslin Diabetes Center has shown that adherence to prescribed dietary recommendations is associated with better glucose control in children with type 1 diabetes.

Researchers at the Joslin Diabetes Center in Boston have discovered that a significant portion of people who have had type 1 diabetes for 50 or more years still have the capacity to produce insulin.

A physician at the FDA provided new data that shows there is a serious problem regarding patient safety in insulin pump use.

For patients with type 1 diabetes and end-stage renal disease (ESRD), simultaneous kidney-pancreas transplantation increases the chances of long-term survival compared to kidney transplantation alone.

Scientists have examined in unprecedented detail the immune cells long thought to be responsible for type 1 diabetes. They caught the immune cells, known as dendritic cells, "red-handed": they were carrying insulin and fragments of insulin-producing cells.

A new method that uses nanotechnology to rapidly measure minute amounts of insulin is a major step toward developing the ability to assess the health of the body's insulin-producing cells in real time.

Scientists have discovered a new technique for turning embryonic stem cells into insulin-producing pancreatic tissue in what could prove a significant breakthrough in the quest to find new treatments for diabetes.

New research monitoring the effects of Islet cell transplantation resulted in near-normal metabolic control and decreased hypoglycemia.

Testosterone deficiency, previously recognized as common in men with type 2 diabetes, is also common in men with type 1 diabetes according to a new study.

A research team discovered that in some individuals, the specialized immunoregulatory T-cells that regulate the body's autoimmune reactions may lose their effectiveness and become "lazy" over time, leading to the onset of type 1 diabetes.

A new drug is showing great promise in returning patients with type 1 diabetes to insulin independence.